Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing

Naeem, Muhammad, Majeed, Saman, Hoque, Mubasher Zahir, Ahmad, Irshad·2020·Cells
DOI 10.3390/cells9071608

Cited by (461)

Items 101–200 of 461

  1. CRISPR/Cas9 gene editing: a novel strategy for fighting drug resistance in respiratory disorders
    Bashdar Mahmud Hussen, Zana Baqi Najmadden, Snur Rasool Abdullah, Mohammed Fatih Rasul, Suhad Asad Mustafa, Soudeh Ghafouri‐Fard, Mohammad Naser Taheri · 2024 · Cell Communication and Signaling
  2. CRISPR/Cas based gene editing: marking a new era in medical science
    K. Manjunatha Prasad, Anila George, Nithin Sam Ravi, Kumarasamypet Murugesan Mohankumar · 2021 · Molecular Biology Reports
  3. Hypoxia-directed tumor targeting of CRISPR-Cas9 and HSV-TK suicide gene therapy using lipid nanoparticles
    Alicia M. Davis, Kevin V. Morris, Galina Shevchenko · 2022 · Molecular Therapy — Methods & Clinical Development
  4. A Simple CRISPR/Cas9 System for Efficiently Targeting Genes of Aspergillus Section Flavi Species, Aspergillus nidulans, Aspergillus fumigatus, Aspergillus terreus, and Aspergillus niger
    Perng‐Kuang Chang · 2023 · Microbiology Spectrum
  5. CRISPR/Cas System Toward the Development of Next-Generation Recombinant Vaccines: Current Scenario and Future Prospects
    Muhammad Naeem, Hanoof Fahad Alkhodairy, Iqra Ashraf, Amjad Bajes Khalil · 2022 · Arabian Journal for Science and Engineering
  6. The landscape of CRISPR/Cas9 for inborn errors of metabolism
    Andrés Felipe Leal, Fnu Nidhi, Eliana Benincore-Flórez, Angelica María Herreño-Pachón, Olga Yaneth Echeverri-Peña, Carlos Javier Alméciga-Díaz, Shunji Tomatsu · 2022 · Molecular Genetics and Metabolism
  7. Supporting crop plant resilience during climate change
    Yuxuan Yuan, Linh Bao Ton, William J. W. Thomas, Jacqueline Batley, David Edwards · 2023 · Crop Science
  8. Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1
    Seren Marsh, Britt Hanson, Matthew J. A. Wood, Miguel A. Varela, Thomas C. Roberts · 2020 · Molecular Therapy
  9. A review of tamoxifen administration regimen optimization for Cre/loxp system in mouse bone study
    Mingyang Chen, Fu-Lin Zhao, Wen-Lin Chu, Mingru Bai, Demao Zhang · 2023 · Biomedicine & Pharmacotherapy
  10. Exploring the Potential and Challenges of CRISPR Delivery and Therapeutics for Genetic Disease Treatment
    Xinpu Yang, Thuy Anh Bui, Haoqi Mei, Yagiz Alp Aksoy, Fei Deng, György Hutvágner, Wei Deng · 2024 · Advanced Functional Materials
  11. Tumor microenvironment–responsive nanoformulations for breast cancer
    Pallavi Dasharath Velapure, Divyanshi kansal, Chandrashekhar Digambar Bobade · 2024 · Discover Nano
  12. Advances in CRISPR/Cas9 genome editing for crop improvement and global food security
    Saba Haider, Aditya Pratap Singh, Binod Panthi, Shilpi R Sindhu, Nishat Tasnim Safa, Saira Malik, Mehdi Rahimi · 2026 · Current Plant Biology
  13. RETRACTED: CRISPR/Cas9: A revolutionary genome editing tool for human cancers treatment
    Fatima Akram, Ikram ul Haq, Sania Sahreen, Narmeen Nasir, Waqas Naseem, Memoona Imitaz, Amna Aqeel · 2022 · Technology in Cancer Research & Treatment · Retracted
  14. Boosting CAR-T cell therapy with CRISPR technology
    Liyanran Yan, Shanzi Gao, Xinhui Wang, Xintao Zhou, Praopim Limsakul, Yiqian Wu · 2024 · hLife
  15. CRISPR Genome Editing Technology: A Powerful Tool Applied to Developing Agribusiness
    Mariana Rocha Maximiano, Fabiano T. P. K. Távora, Guilherme Souza Prado, Simoni Campos Dias, Ângela Mehta, Octávio Luiz Franco · 2021 · Journal of Agricultural and Food Chemistry
  16. CRISPR and KRAS: a match yet to be made
    Guzide Bender, Rezan Fahrioglu Yamaci, Bahar Taneri · 2021 · Journal of Biomedical Science
  17. Heritable genome editing: ethical aspects of a developing domain
    Seppe Segers · 2023 · Human Reproduction
  18. CRISPR, CAR-T, and NK: Current applications and future perspectives
    Mohadeseh Khoshandam, Hossein Soltaninejad, Amir Ali Hamidieh, Saman Hosseinkhani · 2023 · Genes & Diseases
  19. Tips, Tricks, and Potential Pitfalls of CRISPR Genome Editing in Saccharomyces cerevisiae
    Jacob S. Antony, John M. Hinz, John J. Wyrick · 2022 · Frontiers in Bioengineering and Biotechnology
  20. Genetic engineering and genome editing in plants, animals and humans: Facts and myths
    Maria Platani, Owolabi Emmanuel Sokefun, Elias Bassil, Yiorgos Apidianakis · 2022 · Gene
  21. CRISPR/Cas and artificial intelligence to improve precision medicine: Future perspectives and potential limitations
    Mohadeseh Khoshandam, Hossein Soltaninejad, Saman Hosseinkhani, Zohreh Saltanatpour, Mohammad Taghi Hedayati Goudarzi, Amir Ali Hamidieh · 2024 · Human Gene
  22. Recent advances in CRISPR-Cas system for Saccharomyces cerevisiae engineering
    Xinxin Wu, Xiaowen Wan, Hongbin Yu, Huayi Liu · 2025 · Biotechnology Advances
  23. CRISPR Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential
    Bahareh Farasati Far, Marziyeh Akbari, Mohammad Amin Habibi, Morteza Katavand, Sherko Nasseri · 2025 · Cell Proliferation
  24. Implications of the EFSA Scientific Opinion on Site Directed Nucleases 1 and 2 for Risk Assessment of Genome-Edited Plants in the EU
    Nils Rostoks · 2021 · Agronomy
  25. Agronomic and genetic approaches for enhancing tolerance to heat stress in rice: a review
    Adnan Rasheed, Mahmoud Fathy Seleiman, Muhammad Nawaz, Athar Mahmood, Muhammad Rizwan Anwar, Muhammad Ahsin Ayub, Muhammad Aamer, Mohamed Ahmed El-Esawi, Ehab H. El-Harty, Maria BATOOL et al. · 2021 · Notulae Botanicae Horti Agrobotanici Cluj-Napoca
  26. Improving environmental stress resilience in crops by genome editing: insights from extremophile plants
    Mohamed Kouhen, Pedro García‐Caparrós, Richard M. Twyman, Chédly Abdelly, Henda Mahmoudi, Stefan Schillberg, Ahmed Debez · 2022 · Critical Reviews in Biotechnology
  27. A Markerless CRISPR-Mediated System for Genome Editing in Candida auris Reveals a Conserved Role for Cas5 in the Caspofungin Response
    Craig L. Ennis, Aaron D. Hernday, Clarissa J. Nobile · 2021 · Microbiology Spectrum
  28. Learning to quantify uncertainty in off-target activity for CRISPR guide RNAs
    Özden, Furkan, Minary, Peter · 2024 · Nucleic Acids Research
  29. Nanogels: Smart tools to enlarge the therapeutic window of gene therapy
    Bruno Espuche, Sergio Enrique Moya, Marcelo Calderón · 2024 · International Journal of Pharmaceutics
  30. An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology
    Mina Roueinfar, Hayley Templeton, Julietta A. Sheng, Ka Lok Hong · 2022 · Molecules
  31. CRISPR–Cas technologies in neurodegenerative disorders: mechanistic insights, therapeutic potential, and translational challenges
    Raya Kh. Yashooa, Ari Qadir Nabi, Shukur Wasman Smail, Sarkar Sardar Azeez, Wissam Albeer Nooh, Suhad Asad Mustafa, Abd Al-Bar Al-Farha, Nazzareno Capitanio, Mudhir Sabir Shekha · 2026 · Frontiers in Neurology
  32. In Search of Molecular Markers for Cerebellar Neurons
    Wing Yip Tam, Xia Wang, Andy S. K. Cheng, Kwok‐Kuen Cheung · 2021 · International Journal of Molecular Sciences
  33. Modification of Fatty Acid Profile and Oil Contents Using Gene Editing in Oilseed Crops for a Changing Climate
    Saeed Rauf, Seerat Fatima, Rodomiro Octavio Ortiz · 2023 · GM crops & food
  34. Supramolecular Genome Editing: Targeted Delivery and Endogenous Activation of CRISPR/Cas9 by Dynamic Host‐Guest Recognition
    Bowen Li, Qing Li, Zidan Qi, Zhiyao Li, Xiaojie Yan, Yuan Chen, Xiaojie Xu, Qi Pan, Yuxuan Chen, Feihe Huang et al. · 2024 · Angewandte Chemie International Edition
  35. Comprehensive analysis of off-target and on-target effects resulting from liver-directed CRISPR-Cas9-mediated gene targeting with AAV vectors
    Kshitiz Singh, Raffaele Fronza, Hanneke Evens, Marinee Chuah, Thierry VandenDriessche · 2024 · Molecular Therapy — Methods & Clinical Development
  36. Advancements in CRISPR‐Mediated Multiplex Genome Editing: Transforming Plant Breeding for Crop Improvement and Polygenic Trait Engineering
    Uday Kumar, Dyumn Dwivedi, Uddalak Das · 2025 · Biotechnology Journal
  37. Mechanistic insights into the versatile class II CRISPR toolbox
    Fan Zhang, Zhiwei Huang · 2021 · Trends in Biochemical Sciences
  38. Three strategies of transgenic manipulation for crop improvement
    Haoqiang Yu, Qingqing Yang, Fengling Fu, Wanchen Li · 2022 · Frontiers in Plant Science
  39. Multiplexed engineering and precision gene editing in cellular immunotherapy
    Alexander Biederstädt, Gohar Shahwar Manzar, May Daher · 2022 · Frontiers in Immunology
  40. Seed sequences mediate off-target activity in the CRISPR-interference system
    Neha Rohatgi, Jean‐Philippe Fortin, Ted Lau, Yi Ying, Yue Zhang, Bettina L. Lee, Michael Rodrigues Costa, Rohit Reja · 2024 · Cell Genomics
  41. CRISPR genome engineering for retinal diseases
    Ariel Kantor, Michelle E. McClements, Caroline F. Peddle, Lewis E. Fry, Ahmed Salman, Jasmina Cehajic‐Kapetanovic, Kanmin Xue, Robert Edward MacLaren · 2021 · Progress in molecular biology and translational science
  42. CRISPR/Cas9 Technology as a Modern Genetic Manipulation Tool for Recapitulating of Neurodegenerative Disorders in Large Animal Models
    Mahdi Barazesh, Shiva Mohammadi, Yadollah Bahrami, Pooneh Mokarram, Mohammad Hossein Morowvat, Massoud Saidijam, Morteza Karimipoor, Soudabeh Kavousipour, Amir Reza Vosoughi, Korosh Khanaki · 2020 · Current Gene Therapy
  43. CRISPR-Mediated Base Editing: From Precise Point Mutation to Genome-Wide Engineering in Nonmodel Microbes
    Mengyuan Li, Yi‐Xin Huo, Shuyuan Guo · 2022 · Biology
  44. CRISPR-based biosensor for the detection of Marburg and Ebola virus
    Irkham Irkham, Abdullahi Umar Ibrahim, Pwadubashiyi Coston Pwavodi, Chidi Wilson Nwekwo, Yeni Wahyuni Hartati · 2023 · Sensing and Bio-Sensing Research
  45. Revitalizing oral cancer research: Crispr-Cas9 technology the promise of genetic editing
    Sowmik Das Sowmya, Dominic Augustine, Shazia Mushtaq, Hosam Ali Baeshen, Heba Mahmoud Ashi, Reem Nabil Hassan, Mohammed Alshahrani, Shankargouda Patil · 2024 · Frontiers in Oncology
  46. Genome editing in Sub-Saharan Africa: a game-changing strategy for climate change mitigation and sustainable agriculture
    Peter Amoah, Abdoul-Razak Oumarou Mahamane, Moise Hubert Byiringiro, Neo Jeremiah Mahula, Nyimasata Manneh, Yetunde Ruth Oluwasegun, Abebawork Tilahun Assfaw, Hellen Mawia Mukiti, Abubakar Danlami Garba, Felicity Kido Chiemeke et al. · 2024 · GM crops & food
  47. Smart arginine-equipped polycationic nanoparticles for p/CRISPR delivery into cells
    Pardis Moradi, Akbar Hasanzadeh, Fatemeh Radmanesh, Saideh Rajai‐Daryasarei, Elaheh Sadat Hosseini, Jafar Kiani, Ali Shahbazi, Helena Nourizadeh, Maryam Eslami, Akbar Dorgalaleh et al. · 2021 · Nanotechnology
  48. Genome Editing in Crop Plant Research—Alignment of Expectations and Current Developments
    Meike Hüdig, Natalie Laibach, Anke-Christiane Hein · 2022 · Plants
  49. Efficient genome editing for Pseudomonas aeruginosa using CRISPR-Cas12a
    Zhanglin Lin, Huanhuan Li, Lan He, Yanyun Jing, Marco Pistolozzi, Tingting Wang, Yanrui Ye · 2021 · Gene
  50. Biosafety materials: Ushering in a new era of infectious disease diagnosis and treatment with the CRISPR/Cas system
    Yuquan Zhang, Ziyue Li, Julien Milon Essola, Kun Ge, Xuyan Dai, Huining He, Haihua Xiao, Yuhua Weng, Yuanyu Huang · 2022 · Biosafety and Health
  51. Biological and genetic therapies for the treatment of Duchenne muscular dystrophy
    Harry Wilton-Clark, Toshifumi Yokota · 2022 · Expert Opinion on Biological Therapy
  52. Chitosan nanoplatforms in agriculture for multi-potential applications - Adsorption/removal, sustained release, sensing of pollutants & delivering their alternatives – A comprehensive review
    Ganeshlenin Kandasamy, Ravichandran Manisekaran, Manoj‐Kumar Arthikala · 2023 · Environmental Research
  53. Promises and Pitfalls of Next-Generation Treg Adoptive Immunotherapy
    Panayiota Christofi, Chrysoula Pantazi, Nikoletta Psatha, Ioanna Sakellari, Evangelia Yannaki, Αναστασία Παπαδοπούλου · 2023 · Cancers
  54. Peptide nucleic acids: Recent advancements and future opportunities in biomedical applications
    Achinta Sannigrahi, Nayan De, Debmalya Bhunia, Jhuma Bhadra · 2025 · Bioorganic Chemistry
  55. Uncertainty-aware and interpretable evaluation of Cas9–gRNA and Cas12a–gRNA specificity for fully matched and partially mismatched targets with Deep Kernel Learning
    Bogdan Kirillov, Ekaterina E. Savitskaya, Maxim Panov, Aleksey Y. Ogurtsov, Svetlana A. Shabalina, Eugene V. Koonin, Konstantin Severinov · 2021 · Nucleic Acids Research
  56. Genome editing in the edible fungus Poria cocos using CRISPR-Cas9 system integrating genome-wide off-target prediction and detection
    Zhenni Xie, Can Zhong, Xiaoliu Liu, Ziling Wang, Rongrong Zhou, Jing Xie, Shuihan Zhang, Jian Jin · 2022 · Frontiers in Microbiology
  57. CRISPR/Cas: History and Perspectives
    Anna Shmakova, Shmakova O.P., Anna A. Karpukhina, Yegor S Vassetzky · 2022 · Russian Journal of Developmental Biology
  58. CRISPR Gene Therapy: A Promising One-Time Therapeutic Approach for Transfusion-Dependent β-Thalassemia—CRISPR-Cas9 Gene Editing for β-Thalassemia
    Udani Gamage, Kesari Warnakulasuriya, Sonali Hansika, Gayathri N. Silva · 2023 · Thalassemia Reports
  59. CRISPR-Cas9‒Based Genomic Engineering in Keratinocytes: From Technology to Application
    Jos P.H. Smits, Luca D. Meesters, Berber G.W. Maste, Huiqing Zhou, Patrick L.J.M. Zeeuwen, Ellen H. J. van den Bogaard · 2021 · JID Innovations
  60. Sustainable Agriculture through the Enhancement of Microbial Biocontrol Agents: Current Challenges and New Perspectives
    Arun Gokul, Jabulani Mabaso, Nontuthuko Henema, Laetitia Voua Otomo, Olalekan Olanrewaju Bakare, Ashwil Klein, Augustine Innalegwu Daniel, Aina Omolola, Lee‐Ann Niekerk, Mbukeni Andrew Nkomo et al. · 2023 · Applied Sciences
  61. CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines
    Andréa Witz, Julie Dardare, Aurélie François, Marie Husson, Marie Rouyer, Jessica Demange, Jean‐Louis Merlin, Pauline Gilson, Alexandre Harlé · 2023 · Scientific Reports
  62. Therapeutic applications of CRISPR/Cas9 mediated targeted gene editing in acute lymphoblastic leukemia: current perspectives, future challenges, and clinical implications
    Alan Jhones Barbosa de Assis, Brunna Letícia de Oliveira Santana, Ana Cristina Moura Gualberto, Fabio Pittella-Silva · 2023 · Frontiers in Pharmacology
  63. Applications of CRISPR/Cas as a Toolbox for Hepatitis B Virus Detection and Therapeutics
    Anuj Kumar, Emmanuel Combe, Léa Mougené, Fabien Zoulim, Barbara Testoni · 2024 · Viruses
  64. Redox system and ROS-related disorders in peroxisomes
    Hyunsoo Kim, Jaetaek Hwang, Channy Park, Raekil Park · 2024 · Free Radical Research
  65. Multiplex Site-Directed Gene Editing Using Polyethylene Glycol-Mediated Delivery of CRISPR gRNA:Cas9 Ribonucleoprotein (RNP) Complexes to Carrot Protoplasts
    Magdalena Klimek‐Chodacka, Miron Gieniec, Rafał Barański · 2021 · International Journal of Molecular Sciences
  66. Transgenic Improvement for Biotic Resistance of Crops
    Haoqiang Yu, Yingge Wang, Fengling Fu, Wanchen Li · 2022 · International Journal of Molecular Sciences
  67. Development of CRISPR Cas9, spin-off technologies and their application in model construction and potential therapeutic methods of Parkinson’s disease
    Jiangbo Qu, Na Liu, Lu Gao, Jia Ming Hu, Miao Sun, Dongyi Yu · 2023 · Frontiers in Neuroscience
  68. The immune system of prokaryotes: potential applications and implications for gene editing
    SiYang Maggie Liu, Hongling Liu, Xue Wang, Lei Shi · 2024 · Biotechnology Journal
  69. Effective therapies for sickle cell disease: are we there yet?
    Merlin Crossley, Georgios E. Christakopoulos, Mitchell J. Weiss · 2022 · Trends in Genetics
  70. Responsive MXene nanovehicles deliver CRISPR/Cas12a for boolean logic-controlled gene editing
    Song Wang, Zhenhua Zhang, Rui Tang, Fang He, Yan Huang, Zhou Nie, Chunyang Lei · 2022 · Science China Chemistry
  71. Recent Updates on Corticosteroid-Induced Neuropsychiatric Disorders and Theranostic Advancements through Gene Editing Tools
    Manisha Singh, Vinayak Agarwal, Divya Jindal, Pranav Pancham, Shriya Agarwal, Shalini Mani, R.K. Tiwari, Koushik Das, Badrah Saeed Ali Alghamdi, Tukri S. Abujamel et al. · 2023 · Diagnostics
  72. CRISPR Takes the Front Seat in CART-Cell Development
    Claudia Manriquez-Roman, Elizabeth L. Siegler, Saad S. Kenderian · 2021 · BioDrugs
  73. Gene Augmentation and Editing to Improve TCR Engineered T Cell Therapy against Solid Tumors
    Lo Presti, Vania, Buitenwerf, Frank, van Til, Niek P., Nierkens, Stefan · 2020 · Vaccines
  74. Fortifying crops with micronutrients for sustainable global nutritional security
    Ashish Gautam, Vinay Kumar Sharma, Charupriya Chauhan, Anamika Thakur, Manish Kumar Pandey, Kagolla Priscilla, Rinku Dagar, Xiaoli Jin, Pawan Sukla, Anirudh Kumar et al. · 2025 · Agronomy Journal
  75. Nanoparticle-based non-viral CRISPR delivery for enhanced immunotherapy
    Hyunsu Shin, Jaeyun Kim · 2022 · Chemical Communications
  76. A DNA unwinding equilibrium serves as a checkpoint for CRISPR-Cas12a target discrimination
    Jaideep K. Singh, Kevin G. Liu, Aleiqué Allen, Wei Jiang, Peter Zhifeng Qin · 2023 · Nucleic Acids Research
  77. Advances and applications of CRISPR/Cas-mediated interference in Escherichia coli
    Xiaohui Lim, Congqiang Zhang, Xixian Chen · 2023 · Engineering Microbiology
  78. Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review
    Paulina J. Dziubańska-Kusibab, Ekaterina Nevedomskaya, Bernard Haendler · 2024 · International Journal of Molecular Sciences
  79. CRISPR-Cas9 in the Tailoring of Genetically Engineered Animals
    Wiktoria Urban, Marta Kropacz, Maksymilian Łach, Anna Jankowska · 2025 · Current Issues in Molecular Biology
  80. CaSilico: A versatile CRISPR package for in silico CRISPR RNA designing for Cas12, Cas13, and Cas14
    Adnan Asadbeigi, Milad Norouzi, Mohammad Sadegh Vafaei Sadi, Mojtaba Saffari, Mohammad Reza Bakhtiarizadeh · 2022 · Frontiers in Bioengineering and Biotechnology
  81. Prime Editing: The Next Frontier in Precision Gene Therapy
    Melike Aliciaslan, Ezgi Erbasan, Fulya Erendor, Salih Şanlıoğlu · 2025 · The Journal of Gene Medicine
  82. Non-clinical safety assessment of novel drug modalities: Genome safety perspectives on viral-, nuclease- and nucleotide-based gene therapies
    Myriam Lemmens, Lena Dorsheimer, Andreas Zeller, Yasmin Dietz · 2024 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
  83. Principles and Applications of CRISPR Toolkit in Virus Manipulation, Diagnosis, and Virus-Host Interactions
    Saleh Jamehdor, Sara Pajouhanfar‎, Sadaf Saba, Georges Uzan, Ali Teimoori, Sina Naserian · 2022 · Cells
  84. Immobilized doxorubicin and ribociclib carbamate linkers encaged in surface modified cubosomes spatially target tumor reductive environment to enhance antitumor efficacy
    Madhu Sharma, Dilip Panwar, Pratiksha Tiwari, Ankit Kumar, Shalini Gautam, Disha Marwaha, Nikhil Rai, Neha Singh, Avijit Kumar Bakshi, Neha Agarwal et al. · 2023 · Biomaterials Advances
  85. Structure-transformable poly (thymine) activators of CRISPR/Cas12a for highly sensitive detection of mercury (II) ions
    David Septian Sumanto Marpaung, Yayu Chen, Murali Mohana Rao Singuru, Min‐Chieh Chuang · 2025 · International Journal of Biological Macromolecules
  86. R gene-mediated resistance in the management of plant diseases
    Aditi Tailor, Satish Chander Bhatla · 2023 · Journal of Plant Biochemistry and Biotechnology
  87. CRISPR/Cas9-Engineering for Increased Amylolytic Potential of Microbes for Sustainable Wastewater Treatment: A Review
    Yatika Dixit, Preeti Yadav, Hitakshi Asnani, Arun Kumar Sharma · 2024 · Current Microbiology
  88. CRISPR Technology in Cancer Diagnosis and Treatment: Opportunities and Challenges
    Behrouz Shademan, Sepideh Masjedi, Vahidreza Karamad, Alireza Isazadeh, Fatma Söğütlü, Mohammad hosein saeedi rad, Alireza Nourazarian · 2022 · Biochemical Genetics
  89. Genetic manipulation of photosynthesis to enhance crop productivity under changing environmental conditions
    Abhishek Kumar, Shiv Shanker Pandey, Dhananjay Kumar, Bhumi Nath Tripathi · 2022 · Photosynthesis Research
  90. Traditional Approaches and Emerging Biotechnologies in Grapevine Virology
    Giulia Tarquini, Mattia Dall’Ara, P. Ermacora, Claudio Ratti · 2023 · Viruses
  91. Non-targeting control for MISSION shRNA library silences SNRPD3 leading to cell death or permanent growth arrest
    Maria Czarnek, Katarzyna Sarad, Agnieszka Karaś, Jakub A. Kochan, Joanna Bereta · 2021 · Molecular Therapy — Nucleic Acids
  92. AAV-mediated editing of PMP22 rescues Charcot-Marie-Tooth disease type 1A features in patient-derived iPS Schwann cells
    Yuki Yoshioka, Juliana Bosso Taniguchi, Hidenori Homma, Takuya Tamura, Kyota Fujita, Maiko Inotsume, Kazuhiko Tagawa, Kazuharu Misawa, Naomichi Matsumoto, Masanori Nakagawa et al. · 2023 · Communications Medicine
  93. CRISPER/CAS: A POTENTIAL TOOL FOR GENOMES EDITING
    Sara Rauf, Aniqa Shahid, Muhammad Faizan, Muhammad Nouman Khalid3* and Ifrah Amjad3 · 2023 · Agrobiological Records
  94. Applications of Genome Editing Tools in Stem Cells Towards Regenerative Medicine: An Update
    Wilfried A. Kues, Dharmendra Kumar, Naresh L. Selokar, Thirumala Rao Talluri · 2021 · Current Stem Cell Research & Therapy
  95. Challenges and opportunities when transitioning from in vivo gene replacement to in vivo CRISPR/Cas9 therapies – a spotlight on hemophilia
    Oscar G. Segurado, Ruhong Jiang, Steven W. Pipe · 2022 · Expert Opinion on Biological Therapy
  96. Applications and advancements of CRISPR-Cas in the treatment of lung cancer
    Lei Pan, Yixin Ju, Fenfen Peng, Jie Denny Luo · 2023 · Frontiers in Cell and Developmental Biology
  97. Exploring CRISPR/Cas9 Gene Editing Applications for Enhancing Disease Resistance in Sugar Beet
    Varucha Misra, Himanshu Pandey, Ashutosh Kumar Mall · 2023 · ACS Agricultural Science & Technology
  98. Small nucleic acids and the path to the clinic for anti-CRISPR
    Christopher L. Barkau, Daniel O’Reilly, Seth B. Eddington, Masad José Damha, Keith T. Gagnon · 2021 · Biochemical Pharmacology
  99. Rapid generation of homozygous fluorescent knock-in human cells using CRISPR–Cas9 genome editing and validation by automated imaging and digital PCR screening
    Andrea Callegari, Moritz Kueblbeck, Natalia Rosalía Morero, Beatriz Serrano‐Solano, Jan Ellenberg · 2024 · Nature Protocols
  100. Improving the use of CRISPR/Cas9 gene editing machinery as a cancer therapeutic tool with the help of nanomedicine
    Hina Fatima, Dimple Singh, Huzaifa Muhammad, Swati Acharya, Mohammad Azhar Aziz · 2024 · 3 Biotech